Our #healthec analysis shows ICU costs for participants in PCR intervention arm were lower in all scenarios analysed, Those in the BioFire Diagnostics (now bioMérieux) Pneumonia Panel arm had an average saving of £9,940 for the ICU stay.

80% of clinicians believed molecular diagnostics but concerns such as fears of patient deterioration drove non-adherence to both the trial prescribing algorithm and hospital guidelines.

Rob Horne: One major finding of our behaviour work was that clinicians do not sufficiently consider the immediate harms of broad-spectrum antibiotics. Future antibiotic stewardship interventions should focus on this. #eccmid2023

Don’t miss INHALE RCT trial results of POCT multiplex pneumonia PCR presented by Dr Vicky Enne 🇪🇺 today at 16:15 in Hall P. #ECCMID2023

Fascinating results from Dagfunn Markussen demonstrating that “high quality” and “low quality” respiratory samples showed no difference in detection of common pneumonia pathogens in CAP patients. #eccmid2023

Excited to share our latest paper from the INHALE research programme INHALE exploring prescribers' attitudes towards using rapid molecular diagnostic technology to guide antibiotic prescribing in ICU patients with pneumonias - open access link: academic.oup.com/jac/advance-ar…

Our latest paper - exploring clinician prescribing behaviour in icu during the covid pandemic.

Great to be in sunny (but very windy) Cascais for #EHPS2024. Looking forward to presenting some of our work from INHALE on Thursday!! ☀️

Flexible job opportunity! We're seeking a research associate to work on the INHALE project. Mainly analyses & data collection. Ideal candidate would have knowledge of microbiology and antimicrobials. Would suit recent graduate or similar. vacancies.uea.ac.uk/vacancies/1242…

We’re expanding our reach! Follow us on: Bluesky: @ Inhale-Trial.bsky.social LinkedIn: INHALE trial (linkedin.com/company/inhale…) For all of the latest news from INHALE.

1/2 The INHALE WP3 randomised trial provides multi-centre evidence that rapid syndromic PCR, delivered at the point-of care in the ICU improved antibiotic stewardship by 21% in absolute terms. Equivalence of clinical cure was not demonstrated. link.springer.com/article/10.100…

INHALE compared rapid testing with standard care used to diagnose pneumonia in intensive care. Rapid testing gave faster results than standard care and improvements in antibiotic use. But, the machine did not improve cure of pneumonia, so more research is needed to understand why

What is the impact of seeking pathogens by rapid molecular diagnostic methods on antibiotic stewardship and the clinical outcomes in hospital-acquired and ventilator-associated pneumonia? Visual abstract below and full paper available online at rdcu.be/ehlAu

'INHALE Poem II – A slight diversion’ shares the journey of INHALE, describing its hopes, challenges and implications of the research. This poem was written and performed by Amander Wellings, of the INHALE Patient, Carer and Public Involvement (PPI) group youtu.be/-UUBzbSmEo0?fe…

INHALE WP3 RCT health economic analysis now published in Critical Care. The Pneumonia Panel PCR had lower average ICU costs and was cost effective for antimicrobial stewardship, but not clinical cure. Read in full at: rdcu.be/eAmSD